008620-28200517
service@deaou.cn
Registered with Industrial and Commercial Bureau
Product R & D and Transformation
Introduced Angel Investment
Obtained National Medical Instrument Production Certificate
Started clinical trials of mycobacterium tuberculosis diagnostics kit and obtained 3 invention patents
Took the lead for the declaration of the “12th Five-Year Plan” National Major Science and Technology Projects
Passed the medical device production quality system assessment by State Food and Drug Administration
Tuberculosis detection kit passed the assessment by State Food and Drug Administration
National high-tech enterprise The first medical diagnostic product obtained Type III medical instrument registration Took the lead to introduce the economic innovation and developmentindustrialization
demonstration project under State Oceanic Administration
Introduced venture capital investment and strategic investment
The Chief Scientist was selected as the tenth batch of "National Major Talent Project Finalists" expert
The constant-temperature amplification fluorescence detector (Deaou-308C) obtained the medical instrument registration certificate for the first time in China
Beijing Tuberculosis Diagnosis and Treatment Technology Innovation Alliance-Directory Membership Unit
Introduced venture capital investment and strategic investment
The sales volume made a breakthrough on the market
The Anti-tuberculosis Association - Directory Membership Unit set up a sales team to start sales
The transgenosis detection industry standards mainly prepared by Deaou were put into comprehensive effect
2017 Declared the "13th Five-Year Plan" National Major Science and Technology Projects
The Chief Technology Officer was selected as the fourteenth batch of "National Major Talent Project Finalists" expert
Molecular Diagnostics Engineering Technology Research Center in Guangdong Province
SPOTest immune products obtained Type III medical instrument registration
DeFast.TB completed the renewal registration and obtained a new Type III medical instrument registration
Deaou Life Science Research Institute was established
Won an award in the 7th China Innovation & Entrepreneurship Competition
Registered the global leading two-factor product and entered Green Channel for
the priority approval
The third prize of Guangdong Province Science and Technology Progress
Guangdong Provincial Doctor Workstation
Market sales volume was more than 50 million yuan
Obtained project approval for the "Project of Leading Science and Technology Talents in the Development Zone"
"Tuberculosis Prevention and Control Technology Integration and Application Research" won the first prize of Guangdong Province Science and Technology Progress
Won "Tuberculosis Detection and Diagnostic Innovation Team" under AIDS and Tuberculosis Major Projects
Microorganism mass spectrometry detection platform
Ultramicro spectrophotometer
Automatic nucleic acid extraction instrument were launched successfully
Completed a new round of funding up to 40 million yuan
|
|
Guangdong ICP No. 16024184 Guangzhou Deaou Bio-technology Co., Ltd.
Diagnostics
Detecting Instruments
Quality Management System